Search

everythinglearnresearchcommunity

for

Search:↓

Multimodal primary treatment improves survival in premenopausal breast cancer patients and is also beneficial for postmenopausal women.

Telogen effluvium is a common, reversible hair loss condition treatable with patient education and sometimes Minoxidil.

Hair shedding after childbirth can reveal a pre-existing condition of hair loss due to tight hairstyles.

Low ferritin and Vitamin D levels may cause hair loss after COVID-19.

L-Cystine and L-Cystine with Kera-Diet® safely improved hair and nail quality in healthy women.

Stress is likely causing hair loss in Formosan macaques.

Some COVID-19 patients lose hair, with the most common type linked to male hormones and possibly increasing the risk of severe illness.

Hormonal changes during and after pregnancy can cause hair growth changes and hair loss, with treatments available for some conditions.

Pregnancy causes skin changes like darkening, hair thickening, nail changes, and increased risk of skin growths, most of which usually resolve after birth.

Most skin changes during pregnancy are harmless and moles don't significantly change, but many women experience pigmentation changes due to hormones and sun exposure.

The new all-natural shampoo treatment can prevent hair loss and encourage hair regrowth in new mothers.

Most skin changes during pregnancy go away after giving birth.

Pregnancy can cause more body and scalp hair growth and make nails brittle, but these changes often revert after giving birth.

Pregnant women often experience skin and hair changes, with over half getting stretch marks and pigment changes, and should be cautious with cosmetic procedures due to potential risks.

A pregnant woman's skin condition improved after giving birth, possibly due to high estrogen levels during pregnancy.

Menopause can lead to skin and hair problems due to hormonal changes, but hormone replacement therapy might help slow these effects.

Telogen Effluvium (TE) significantly affects women due to stress and hormonal changes, requiring better public health policies and mental health support.

Hormonal status significantly affects women's skin health throughout their lives.

The study aims to understand the skin and hair characteristics of mothers and their babies, and how these may affect newborns' skin health and mothers' postpartum hair loss.

Telogen effluvium is a common hair loss condition where many hairs enter the resting phase, often not noticeable until significant loss occurs, and treatment focuses on the underlying cause.

The document concludes that treating the underlying causes of telogen effluvium usually results in hair regrowth.

Telogen Effluvium is a hair loss condition where treatment involves identifying and managing its triggers.

Common types of non-scarring hair loss have various causes and treatments, but more effective solutions are needed.

The conclusion is that pharmacists are important in helping women choose the right skin care treatments.

Hormones like testosterone and estrogen significantly affect hair growth and structure.

Hair loss from Telogen Effluvium can be managed by treating the underlying cause and may improve with treatments like minoxidil.

Neurosteroids change how GABA_A receptors work in the brain, which could be important for treating temporal lobe epilepsy.

Effective hair loss treatment in women requires correct diagnosis and can include medications like minoxidil, antiandrogens, and treatments for underlying conditions like PCOS.

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Women's hair gets thinner and grayer as they age, with treatments available for hair loss and graying.